93 related articles for article (PubMed ID: 29188452)
1. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
3. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.
Chaplet M; Detry C; Deroanne C; Fisher LW; Castronovo V; Bellahcéne A
Biochem J; 2004 Dec; 384(Pt 3):591-8. PubMed ID: 15324309
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB.
Gao SY; Zheng GS; Wang L; Liang YJ; Zhang SE; Lao XM; Li K; Liao GQ
PLoS One; 2017; 12(6):e0179248. PubMed ID: 28594896
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into the pharmacological modulation of human periodontal ligament stem cells by the amino-bisphosphonate Alendronate.
Di Vito A; Chiarella E; Sovereto J; Bria J; Perrotta ID; Salatino A; Baudi F; Sacco A; Antonelli A; Biamonte F; Barni T; Giudice A
Eur J Cell Biol; 2023 Dec; 102(4):151354. PubMed ID: 37604089
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid.
Hughes R; Chen X; Hunter KD; Hobbs JK; Holen I; Brown NJ
FASEB J; 2019 Nov; 33(11):12768-12779. PubMed ID: 31490705
[TBL] [Abstract][Full Text] [Related]
8. Inhibition Effect of Zoledronate on the Osteoclast Differentiation of RAW264.7 Induced by Titanium Particles.
Zhao W; Huang Z; Lin Y; Lan J; Gao X
Biomed Res Int; 2021; 2021():5578088. PubMed ID: 33763474
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of zoledronic acid on the osteogenic differentiation of human bone marrow stem cells (hBMSCs).
Hadad H; Matheus HR; Chen JE; Jounaidi Y; Souza FÁ; Guastaldi FPS
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6):101479. PubMed ID: 37080358
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Nanoformulation of Zoledronic Acid Rescues Osteoblasts from the Harmful Effect of its Native Form: An In Vitro Investigation of Cytotoxic Potential on Osteoblasts and Osteosarcoma Cells.
Dash P; Samal S; Prasad Panda G; Piras AM; Dash M
Macromol Biosci; 2023 Nov; 23(11):e2300211. PubMed ID: 37384621
[TBL] [Abstract][Full Text] [Related]
11. Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.
Lezcano V; Bellido T; Plotkin LI; Boland R; Morelli S
Arch Biochem Biophys; 2012 Feb; 518(2):95-102. PubMed ID: 22230328
[TBL] [Abstract][Full Text] [Related]
12. Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice.
Isawa M; Karakawa A; Sakai N; Nishina S; Kuritani M; Chatani M; Negishi-Koga T; Sato M; Inoue M; Shimada Y; Takami M
Sci Rep; 2019 Dec; 9(1):19895. PubMed ID: 31882595
[TBL] [Abstract][Full Text] [Related]
13.
Surface LE; Burrow DT; Li J; Park J; Kumar S; Lyu C; Song N; Yu Z; Rajagopal A; Bae Y; Lee BH; Mumm S; Gu CC; Baker JC; Mohseni M; Sum M; Huskey M; Duan S; Bijanki VN; Civitelli R; Gardner MJ; McAndrew CM; Ricci WM; Gurnett CA; Diemer K; Wan F; Costantino CL; Shannon KM; Raje N; Dodson TB; Haber DA; Carette JE; Varadarajan M; Brummelkamp TR; Birsoy K; Sabatini DM; Haller G; Peterson TR
Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434850
[TBL] [Abstract][Full Text] [Related]
14. Probiotic
Yeom J; Ma S; Lim YH
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33805153
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment.
Boran G; Tavakoli S; Dierking I; Kamali AR; Ege D
Sci Rep; 2020 May; 10(1):7827. PubMed ID: 32385391
[TBL] [Abstract][Full Text] [Related]
16. Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients.
Beltran-Bless A; Murshed M; Zakikhani M; Kuchuk I; Bouganim N; Robertson S; Kekre N; Vandermeer L; Li J; Addison CL; Rauch F; Clemons M; Kremer R
Bone Rep; 2021 Dec; 15():101145. PubMed ID: 34841014
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of osteogenic differentiation of human maxillary sinus mesenchymal stem cells using RNA-Seq.
Zhou Y; Jiang R; Zeng J; Chen Y; Ren J; Chen S; Nie E
Heliyon; 2023 Oct; 9(10):e20305. PubMed ID: 37800070
[TBL] [Abstract][Full Text] [Related]
18. The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells.
Budzinska A; Galganski L; Jarmuszkiewicz W
Sci Rep; 2023 Sep; 13(1):16205. PubMed ID: 37758809
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
20. A new multifunctionalized material against multi-drug resistant bacteria and abnormal osteoclast activity.
Boanini E; Torricelli P; Bonvicini F; Cassani MC; Fini M; Gentilomi GA; Bigi A
Eur J Pharm Biopharm; 2018 Jun; 127():120-129. PubMed ID: 29454808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
